What is the mechanism of action of Sitagliptin as a DPP-4 inhibitor, and how does it improve glycemic control by regulating incretin hormones?
IVF Questions & Answers Latest Questions
How does Sitagliptin affect hepatic glucose production, and what role does this reduction play in achieving glycemic stability in type 2 diabetics?
Can Sitagliptin reduce the need for insulin therapy in type 2 diabetes, and what are the benefits of using it as part of a comprehensive treatment plan?
How does Sitagliptin impact beta-cell function in early-stage diabetes, and can it preserve or enhance insulin secretion over time?
What factors determine the effectiveness of Sitagliptin therapy, including patient age, comorbidities, and baseline glycemic control?
How does Sitagliptin improve outcomes in elderly patients with diabetes, and what considerations are necessary for its safe and effective use in this population?
Can Sitagliptin be used in combination with Metformin for enhanced glycemic control, and how does this combination compare to other dual therapies?
What are the contraindications for prescribing Sitagliptin, and in which patient groups should its use be avoided?
How does Sitagliptin compare to Linagliptin in terms of efficacy, safety, and patient adherence for type 2 diabetes management?
Can Sitagliptin delay the progression of prediabetes to full-blown diabetes, and what evidence supports its preventive role in high-risk populations?


